Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.

Disclosure: The author holds a long position in SMR.

← Back to Free Index

SMR

Analysis as of: 2026-03-07

NuScale Power Corporation

NuScale develops small modular nuclear reactor technology and sells related engineering, licensing, and plant services to utilities, industrial customers, and project developers.

ai energy hardware nuclear

On Yahoo Finance ...

Jump to: Summary • Analysis • Opportunity • Risk • Trends • LE Structure • Third Party Analyst Consensus

Summary

Regulatory lead needs first-plant proof

The upside case rests on converting design approval into one bankable U.S. project and one advancing export reference. That can unlock a sharp revenue step-up by 2031, but the valuation already assumes more than paperwork.

Analysis

Thesis

NuScale is a leveraged option on AI-era power scarcity: if its U.S. regulatory lead converts ENTRA1/TVA and Romania into bankable reference projects, revenue can jump non-linearly from engineering fees to module, licensing, and long-duration service economics; if not, the stock remains a premium-priced promise.

Last Economy Alignment

AI raises the value of firm power, and NuScale controls scarce regulatory approval plus licensing know-how. The limiter is commercial conversion, not software commoditization.

Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple

3.2x (from 5 most recent analyses)

Reasoning

The stock can work if commercialization moves from studies to binding contracts. A financed first U.S. project plus Romania progress would reframe the company from a licensing story into a scarce nuclear OEM-and-services platform. I am not underwriting mass global rollout by 2031; I am underwriting one credible U.S. reference path, one advancing export path, and attachable services. That supports meaningful upside, but not a mania multiple.

Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary

The core risk is not reactor physics but commercial conversion. NuScale can create major value if one binding U.S. project starts a repeatable bankability loop, but until then it is exposed to timing slips, partner leverage, project-finance friction, dilution, and a valuation that still assumes meaningful success.

Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Trends

Key Changes

February 26, 2026 results confirmed weak near-term conversion but a stronger cash buffer, with 2025 revenue of 31.5 and cash plus investments of 1300.
February 26, 2026 management said definitive ENTRA1/TVA PPA drafting is underway, but no binding U.S. PPA or module order was announced.
February 12, 2026 the ORNL collaboration added an AI-guided fuel-management angle that could lower future plant operating costs, but it does not change the main bankability gate.
March 2, 2026 Citi cut its target to 11.50, reinforcing that sentiment has reset around commercialization timing rather than nuclear demand.
March 5-6, 2026 litigation-solicitation headlines increased after the stock drop, adding volatility but not changing the core operating thesis.

Upgrade to Builder to also access: Future Considerations

Last Economy Structure

AI Industrial Score

0.44

AI makes always-on electricity more valuable, and this company controls a rare U.S.-approved reactor design plus the licensing know-how around it. The risk is simple: those control points only matter if a real customer signs, finances, and starts building a plant.

Upgrade to Reader to also access: Score Decomposition, Confidence Level

Upgrade to Allocator to also access: Obsolescence Vectors, Pricing Fragility

Upgrade to Reader to also access: Constraint Benefit Score, Obsolescence Risk Score

Third Party Analyst Consensus

12-Month Price Target

$21.42

Upgrade to Reader to also access: Bull Case, Base Case, Bear Case

Next Arc Research